Literature DB >> 16180227

MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883.

Mitchell D Schnall1, Jeffery Blume, David A Bluemke, Gia A Deangelis, Nanette Debruhl, Steven Harms, Sylvia H Heywang-Köbrunner, Nola Hylton, Christiane K Kuhl, Etta D Pisano, Petrina Causer, Stuart J Schnitt, Stanley F Smazal, Carol B Stelling, Constance Lehman, Paul T Weatherall, Constantine A Gatsonis.   

Abstract

BACKGROUND: Prior single institution studies suggest MRI may improve the assessment of the extent of cancer within the breast, and thus reduce the risk of leaving macroscopic disease in the breast following breast conservation therapy. We report on the rate of MRI and mammography detection of foci of distinct incidental cancer in a prospective, multi center trial involving 426 women with confirmed breast cancer at 15 institutions in the US, Canada, and Germany.
METHODS: Women underwent mammography and MRI prior to biopsy of the suspicious index lesion. Additional incidental lesions (IL) greater than 2 cm from the index lesion that were detected by mammography and MRI were noted and characterized. Biopsy recommendations were associated with ILs given an assessment of suspicious or highly suspicous (BiRads 4 and 5). These assessments were considered a positive test.
RESULTS: MRI had a significantly higher yield of confirmed cancer ILs than mammography (0.18 (95%CI: 0.142-0.214) for MRI versus 0.072 (95%CI: 0.050-0.100) for mammography). The cancer ILs detected by MRI alone appeared to be similar to those detected by mammography with respect to size and histology. The percentage of biopsies of ILs that resulted in a cancer diagnosis was similar between the modalities (MRI 0.72(95%CI: 0.6-0.81); Mammography 0.85 (95%CI: 0.62-0.96)).
CONCLUSIONS: These results suggest that consideration needs to be given regarding the integration of breast MRI into the pretreatment evaluation of women seeking breast conservation therapy.

Entities:  

Mesh:

Year:  2005        PMID: 16180227     DOI: 10.1002/jso.20381

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  37 in total

1.  Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.

Authors:  Wendie A Berg; Kathleen S Madsen; Kathy Schilling; Marie Tartar; Etta D Pisano; Linda Hovanessian Larsen; Deepa Narayanan; Al Ozonoff; Joel P Miller; Judith E Kalinyak
Journal:  Radiology       Date:  2010-11-12       Impact factor: 11.105

Review 2.  Technical aspects of breast MRI--do they affect outcomes?

Authors:  Ruth Warren; Stefano Ciatto; Petra Macaskill; Richard Black; Nehmat Houssami
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

3.  Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium.

Authors:  Wendy B DeMartini; Laura Ichikawa; Bonnie C Yankaskas; Diana Buist; Karla Kerlikowske; Berta Geller; Tracy Onega; Robert D Rosenberg; Constance D Lehman
Journal:  J Am Coll Radiol       Date:  2010-11       Impact factor: 5.532

4.  Imaging studies for the early detection of breast cancer.

Authors:  Sylvia H Heywang-Köbrunner; Ingrid Schreer; Walter Heindel; Alexander Katalinic
Journal:  Dtsch Arztebl Int       Date:  2008-08-04       Impact factor: 5.594

5.  Additional findings at preoperative breast MRI: the value of second-look digital breast tomosynthesis.

Authors:  Paola Clauser; Luca A Carbonaro; Martina Pancot; Rossano Girometti; Massimo Bazzocchi; Chiara Zuiani; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 6.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.

Authors:  Carrie B Hruska; Michael K O'Connor
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

7.  Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer.

Authors:  Louise M Henderson; Julie Weiss; Rebecca A Hubbard; Cristina O'Donoghue; Wendy B DeMartini; Diana S M Buist; Karla Kerlikowske; Martha Goodrich; Beth Virnig; Anna N A Tosteson; Constance D Lehman; Tracy Onega
Journal:  Breast J       Date:  2015-10-28       Impact factor: 2.431

8.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Authors:  Nola M Hylton; Jeffrey D Blume; Wanda K Bernreuter; Etta D Pisano; Mark A Rosen; Elizabeth A Morris; Paul T Weatherall; Constance D Lehman; Gillian M Newstead; Sandra Polin; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

9.  Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging.

Authors:  Sana Parsian; Habib Rahbar; Kimberly H Allison; Wendy B Demartini; Matthew L Olson; Constance D Lehman; Savannah C Partridge
Journal:  Radiology       Date:  2012-10-02       Impact factor: 11.105

Review 10.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.